Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation

PaperCitations, authors & open-access status

Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 17 citations, 2019 year and gold oa status.

17
Citations
2019
Year
gold
OA Status

Related on ScholarIQ

Kazunori Karasawa
Author
Scientific Reports
Journal
Fibroblast Growth Factor Research
Topic
Fibroblast Growth Factor Research
Topic
Genetic Syndromes and Imprinting
Topic
Epigenetics and DNA Methylation
Topic
470M+ articles · free account